484 related articles for article (PubMed ID: 18326555)
1. Imatinib mesylate attenuates fibrosis in coxsackievirus b3-induced chronic myocarditis.
Leipner C; Grün K; Müller A; Buchdunger E; Borsi L; Kosmehl H; Berndt A; Janik T; Uecker A; Kiehntopf M; Böhmer FD
Cardiovasc Res; 2008 Jul; 79(1):118-26. PubMed ID: 18326555
[TBL] [Abstract][Full Text] [Related]
2. Elevated expression of PDGF-C in coxsackievirus B3-induced chronic myocarditis.
Grün K; Markova B; Böhmer FD; Berndt A; Kosmehl H; Leipner C
Eur Heart J; 2005 Apr; 26(7):728-39. PubMed ID: 15757958
[TBL] [Abstract][Full Text] [Related]
3. Osteopontin: a fibrosis-related marker molecule in cardiac remodeling of enterovirus myocarditis in the susceptible host.
Szalay G; Sauter M; Haberland M; Zuegel U; Steinmeyer A; Kandolf R; Klingel K
Circ Res; 2009 Apr; 104(7):851-9. PubMed ID: 19246678
[TBL] [Abstract][Full Text] [Related]
4. Linkage between elevated PDGF-C expression and myocardial fibrogenesis in coxsackievirus B3-induced chronic myocarditis.
Yang D; Qiu D
Eur Heart J; 2005 Apr; 26(7):642-3. PubMed ID: 15757957
[No Abstract] [Full Text] [Related]
5. Persistent expression of cytokines in the chronic stage of CVB3-induced myocarditis in NMRI mice.
Glück B; Schmidtke M; Merkle I; Stelzner A; Gemsa D
J Mol Cell Cardiol; 2001 Sep; 33(9):1615-26. PubMed ID: 11549341
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of urokinase-type plasminogen activator or matrix metalloproteinases prevents cardiac injury and dysfunction during viral myocarditis.
Heymans S; Pauschinger M; De Palma A; Kallwellis-Opara A; Rutschow S; Swinnen M; Vanhoutte D; Gao F; Torpai R; Baker AH; Padalko E; Neyts J; Schultheiss HP; Van de Werf F; Carmeliet P; Pinto YM
Circulation; 2006 Aug; 114(6):565-73. PubMed ID: 16880329
[TBL] [Abstract][Full Text] [Related]
7. The role of platelet-derived growth factor signaling in healing myocardial infarcts.
Zymek P; Bujak M; Chatila K; Cieslak A; Thakker G; Entman ML; Frangogiannis NG
J Am Coll Cardiol; 2006 Dec; 48(11):2315-23. PubMed ID: 17161265
[TBL] [Abstract][Full Text] [Related]
8. Imatinib mesylate reduces production of extracellular matrix and prevents development of experimental dermal fibrosis.
Distler JH; Jüngel A; Huber LC; Schulze-Horsel U; Zwerina J; Gay RE; Michel BA; Hauser T; Schett G; Gay S; Distler O
Arthritis Rheum; 2007 Jan; 56(1):311-22. PubMed ID: 17195235
[TBL] [Abstract][Full Text] [Related]
9. Platelet-derived growth factor, transforming growth factor-beta, and connective tissue growth factor in a porcine bronchial model of obliterative bronchiolitis.
Alho HS; Maasilta PK; Vainikka T; Salminen US
Exp Lung Res; 2007 Aug; 33(6):303-20. PubMed ID: 17694440
[TBL] [Abstract][Full Text] [Related]
10. Change in the cells that express connective tissue growth factor in acute Coxsackievirus-induced myocardial fibrosis in mouse.
Yun SH; Shin JO; Lim BK; Kim KL; Gil CO; Kim DK; Jeon ES
Virus Res; 2007 Jun; 126(1-2):62-8. PubMed ID: 17350707
[TBL] [Abstract][Full Text] [Related]
11. Ablation of matrix metalloproteinase-9 increases severity of viral myocarditis in mice.
Cheung C; Marchant D; Walker EK; Luo Z; Zhang J; Yanagawa B; Rahmani M; Cox J; Overall C; Senior RM; Luo H; McManus BM
Circulation; 2008 Mar; 117(12):1574-82. PubMed ID: 18332263
[TBL] [Abstract][Full Text] [Related]
12. Coxsackievirus B3-induced myocarditis in MHC class II-deficient mice.
Leipner C; Borchers M; Merkle I; Stelzner A
J Hum Virol; 1999; 2(2):102-14. PubMed ID: 10225212
[TBL] [Abstract][Full Text] [Related]
13. Coxsackievirus B3 infection induced viral myocarditis by regulating the expression pattern of chemokines in cardiac myocytes.
Shen Y; Kan QC; Xu W; Chu YW; Xiong SD
Iran J Allergy Asthma Immunol; 2009 Mar; 8(1):1-9. PubMed ID: 19279353
[TBL] [Abstract][Full Text] [Related]
14. Immunomodulation by interleukin-4 suppresses matrix metalloproteinases and improves cardiac function in murine myocarditis.
Li J; Leschka S; Rutschow S; Schwimmbeck PL; Husmann L; Noutsias M; Westermann D; Poller W; Zeichhardt H; Klingel K; Tschope C; Schultheiss HP; Pauschinger M
Eur J Pharmacol; 2007 Jan; 554(1):60-8. PubMed ID: 17113076
[TBL] [Abstract][Full Text] [Related]
15. Targeting stromal cells for the treatment of platelet-derived growth factor C-induced hepatocellular carcinogenesis.
Campbell JS; Johnson MM; Bauer RL; Hudkins KL; Gilbertson DG; Riehle KJ; Yeh MM; Alpers CE; Fausto N
Differentiation; 2007 Nov; 75(9):843-52. PubMed ID: 17999742
[TBL] [Abstract][Full Text] [Related]
16. Cytokine profiles in heart, spleen, and thymus during the acute stage of experimental coxsackievirus B3-induced chronic myocarditis.
Schmidtke M; Glück B; Merkle I; Hofmann P; Stelzner A; Gemsa D
J Med Virol; 2000 Aug; 61(4):518-26. PubMed ID: 10897072
[TBL] [Abstract][Full Text] [Related]
17. CXCL10 inhibits viral replication through recruitment of natural killer cells in coxsackievirus B3-induced myocarditis.
Yuan J; Liu Z; Lim T; Zhang H; He J; Walker E; Shier C; Wang Y; Su Y; Sall A; McManus B; Yang D
Circ Res; 2009 Mar; 104(5):628-38. PubMed ID: 19168435
[TBL] [Abstract][Full Text] [Related]
18. The viral genetic background determines the outcome of coxsackievirus B3 infection in outbred NMRI mice.
Schmidtke M; Merkle I; Klingel K; Hammerschmidt E; Zautner AE; Wutzler P
J Med Virol; 2007 Sep; 79(9):1334-42. PubMed ID: 17607777
[TBL] [Abstract][Full Text] [Related]
19. Differential macrophage polarization in male and female BALB/c mice infected with coxsackievirus B3 defines susceptibility to viral myocarditis.
Li K; Xu W; Guo Q; Jiang Z; Wang P; Yue Y; Xiong S
Circ Res; 2009 Aug; 105(4):353-64. PubMed ID: 19608981
[TBL] [Abstract][Full Text] [Related]
20. Imatinib mesylate attenuates myocardial remodeling through inhibition of platelet-derived growth factor and transforming growth factor activation in a rat model of hypertension.
Jang SW; Ihm SH; Choo EH; Kim OR; Chang K; Park CS; Kim HY; Seung KB
Hypertension; 2014 Jun; 63(6):1228-34. PubMed ID: 24591339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]